Search alternatives:
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
we decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1381
GC-MS chromatogram of garlic essential oil.
Published 2025“…The inclusion of GO-GA NPs at LC<sub>40</sub> had a significant post-effect on progeny production of <i><i>C. maculatus</i></i>, resulting in a significant reduction in the number of deposited eggs and adult emergence, which led to a significant decrease in the percentage of adult emergence to 15.23 ± 5.46 compared to 61.33 ± 2.94, as observed in the GO treatment. …”
-
1382
Food intake in groups A, B and C.
Published 2025“…Statistically, there was a significant decrease in EPG values from days 0–14. …”
-
1383
-
1384
Summary of post-treatment disease course measures from MDMA-AT publications.
Published 2025Subjects: -
1385
Summary of post-treatment CAPS score changes from clinical trials with FDA-approved medications.
Published 2025Subjects: -
1386
-
1387
-
1388
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
1389
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
1390
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
1391
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
1392
-
1393
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
1394
Ultrafine Particulate Matter Exacerbates the Risk of Delayed Neural Differentiation: Modulation Role of METTL3-Mediated m<sup>6</sup>A Modification
Published 2025“…By employing <i>N</i>6-methyladenosine (m<sup>6</sup>A) methylated RNA immunoprecipitation sequencing and bioinformatics, we identified <i>Zic1</i> as a key target of PM<sub>0.1</sub>-induced developmental disturbances. …”
-
1395
-
1396
-
1397
-
1398
Open data.
Published 2025“…</p><p>Results</p><p>There was a significant decrease in BMD in the lumbar spine (1.107 ± 0.109 and 1.075 ± 0.112 g/cm<sup>2</sup>; <i><i>p</i></i> < 0.001), total body (1.135 ± 0.086 and 1.119 ± 0.085 g/cm<sup>2</sup>; <i><i>p</i></i> < 0.001), and total proximal femur over the six months of EBF compared to the values obtained from the same EBF group at 15 days postpartum (mean percentage decreases in BMD of −3.4 ± 3.7% (<i><i>p</i></i> < 0.001) in lumbar spine, −2.5 ± 3.4% (<i><i>p</i></i> < 0.001) in total proximal femur, and −1.7 ± 1.9% (<i><i>p</i></i> = 0.001) in total body). …”
-
1399
-
1400